Corbus Pharmaceuticals Holdings Inc. (CRBP) stock is nearly perfect except the valuation

The closing price of Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) was $0.14 for the day, up 0.07% from the previous closing price of $0.14. In other words, the price has increased by $+0.0001 from its previous closing price. On the day, 901700 shares were traded. CRBP stock price reached its highest trading level at $0.1450 during the session, while it also had its lowest trading level at $0.1356.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.



Our analysis of CRBP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.90 and its Current Ratio is at 3.90. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.22.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, ROTH Capital on September 08, 2020, Downgraded its rating to Neutral and sets its target price to $3 from $40 previously.

Jefferies Downgraded its Buy to Hold on September 08, 2020, whereas the target price for the stock was revised from $18 to $2.50.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 10 when Millian Craig Stuart bought 5,000 shares for $0.25 per share. The transaction valued at 1,272 led to the insider holds 27,000 shares of the business.

Moran Sean F. bought 20,000 shares of CRBP for $5,198 on Aug 10. The Chief Financial Officer now owns 199,272 shares after completing the transaction at $0.26 per share. On Aug 10, another insider, Cohen Yuval, who serves as the Chief Executive Officer of the company, bought 3,800 shares for $0.26 each. As a result, the insider paid 1,003 and bolstered with 98,230 shares of the company.

Stock Price History:

Over the past 52 weeks, CRBP has reached a high of $0.62, while it has fallen to a 52-week low of $0.10. The 50-Day Moving Average of the stock is 0.1274, while the 200-Day Moving Average is calculated to be 0.2192.

Shares Statistics:

CRBP traded an average of 4.85M shares per day over the past three months and 1.46M shares per day over the past ten days. A total of 125.27M shares are outstanding, with a floating share count of 124.68M. Insiders hold about 0.30% of the company’s shares, while institutions hold 19.00% stake in the company. Shares short for CRBP as of Oct 13, 2022 were 3.9M with a Short Ratio of 3.68M, compared to 3.36M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.12% and a Short% of Float of 3.13%.

Earnings Estimates

The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.07, while EPS last year was -$0.02. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.07.

Analysts are recommending an EPS of between -$0.26 and -$0.32 for the fiscal current year, implying an average EPS of -$0.29. EPS for the following year is -$0.26, with 2 analysts recommending between -$0.24 and -$0.29.